MyChesCo on MSN
Neuronetics Gains Breakthrough as New York Medicaid Expands Coverage for TMS Depression Therapy
Neuronetics, Inc. (NASDAQ: STIM) announced Wednesday that New York State Medicaid will begin covering transcranial magnetic stimulation (TMS) for adults with major depressive disorder (MDD), a move ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback